[go: up one dir, main page]

Lipman et al., 1997 - Google Patents

Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease

Lipman et al., 1997

Document ID
9559299120628128795
Author
Lipman M
Johnson M
Poulter L
Publication year
Publication venue
Aids

External Links

Snippet

Objective: We have compared the phenotypic and functional changes found in alveolar macrophages recovered from the lungs of 39 HIV-positive individuals with no respiratory disease with those from 33 HIV-positive individuals with pneumonitis and 31 healthy …
Continue reading at journals.lww.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Skowera et al. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome
Zedler et al. T-cell reactivity and its predictive role in immunosuppression after burns
Eysteinsdottir et al. The influence of partial or total thymectomy during open heart surgery in infants on the immune function later in life
O'Mahony et al. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production
Krug et al. Cytokine profile of bronchoalveolar lavage–derived CD4+, CD8+, and γδ T cells in people with asthma after segmental allergen challenge
Peruhype-Magalhaes et al. Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-γ and interleukin-10 and low frequency of tumour necrosis factor-α+ monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection
Oyaizu et al. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion
Sandmand et al. Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?
Curnow et al. Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling
Özenci et al. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)-and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment
Girard et al. Impaired function of regulatory T-cells in hypersensitivity pneumonitis
Sasson et al. Increased Plasma Interleukin-7 Level correlates with decreased CDl27 and increased CD132 extracellular expression on T Cell subsets in patients with HN-1 infection
Perry et al. Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
Vigano et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume
La Via et al. The influence of stress intrusion on immunodepression in generalized anxiety disorder patients and controls
Stallmach et al. Increased state of activation of CD4 positive T cells and elevated interferon γ production in pouchitis
Zedler et al. Postburn Constitutional Changes in T-cell Reactivity Occur in CD8 sup+ Rather than in CD4 sup+ Cells
Guazzarotti et al. T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome)
Cutler et al. Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trial
Sakakibara et al. Basophil activation by mosquito extracts in patients with hypersensitivity to mosquito bites
Lipman et al. Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease
Silveira-Nunes et al. Lifewide profile of cytokine production by innate and adaptive immune cells from Brazilian individuals
Li et al. Syphilis infection differentially regulates the phenotype and function of γδ T cells in HIV-1-infected patients depends on the HIV-1 disease stage
Matsumoto et al. Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics
Karttunen et al. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets